Expert Interview
Third View: Discussing Celldex's Phase 2 results for Barzolvolimab for patients with eosinophilic esophagitis (EoE).
Ticker(s): CLDXInstitution: Gastro Intestinal Associates
- Board Certified Gastroenterologist in private practice in Colombus MO.
- Treats 250+ patients with NERD per year.
- Clinical interest includes biologic therapy in Crohn’s Disease, Lemierre’s syndrome, and probiotic therapy.
Do you want answers to these questions?
Slingshot Insights Explained
- Call Date
- Jun 05, 2025
- Call Time
- 04:00 PM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
